©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Functional Expression of Subunit IV of Rhodobacter sphaeroides Cytochrome b-c Complex and Reconstitution of Recombinant Protein with Three-subunit Core Complex (*)

(Received for publication, September 11, 1995; and in revised form, November 15, 1995)

Yeong-Renn Chen Chang-An Yu Linda Yu

From the Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, Oklahoma 74078

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Subunit IV of Rhodobacter sphaeroides cytochrome b-c(1) complex was over-expressed in Escherichia coli JM109 cells as a glutathione S-transferase fusion protein (GST-RSIV) using the expression vector, pGEX/RSIV. Maximum yield of soluble active recombinant fusion protein was obtained from cells harvested 3 h after induction of growth at 37 °C in LB medium. Subunit IV was released from the fusion protein by proteolytic cleavage with thrombin. When subjected to SDS-polyacrylamide gel electrophoresis, isolated recombinant subunit IV showed one protein band corresponding to subunit IV of R. sphaeroides cytochrome b-c(1) complex. Although the isolated recombinant subunit IV is soluble in aqueous solution, it is in a highly aggregated form, with an apparent molecular mass of over 1000 kDa. The addition of detergent deaggregates the isolated protein, suggesting that the recombinant protein exists as a hydrophobic aggregation in aqueous solution. When the three-subunit core cytochrome b-c(1) complex, purified from RSDeltaIV-adapted chromatophores containing a fraction of the wild-type cytochrome b-c(1) complex activity, was reacted with varying amounts of recombinant subunit IV, the activity increased as the subunit IV concentration increased. Maximum activity restoration was reached when 1 mol of subunit IV/mol of three-subunit core complex was used. The reconstituted cytochrome b-c(1) complex is similar to the wild-type complex in molecular size, apparent K for Q(2)H(2), and inhibitor sensitivity, indicating that recombinant subunit IV is properly assembled into the active cytochrome b-c(1) complex. A tryptophan residue in subunit IV was found to be involved in the interaction with the three-subunit core complex.


INTRODUCTION

The Rhodobacter sphaeroides cytochrome b-c(1) complex, which catalyzes the electron transfer from ubiquinol to cytochrome c(2)(1) , has been purified and characterized in several laboratories(2, 3, 4, 5, 6) . The purified complex contains four protein subunits with molecular masses of 43, 31, 23, and 15 kDa. The three largest subunits house cytochrome b, cytochrome c(1), and a high potential [2Fe-2S] Reiske iron-sulfur cluster. The smallest protein subunit (subunit IV) has been proven to be an integral part of the complex by immunochemical studies(7) . Subunit IV and cytochrome b have been identified as ubiquinone (Q)(^1)-binding proteins in the complex by photoaffinity labeling techniques using azido-Q derivatives(8) . However, subunit IV is not present in other comparable bacterial cytochrome b-c(1) complexes, such as Rhodospirillum rubrum(9) , Rhodobacter capsulatus(10) , and Paracoccus denitrificans(11) .

The involvement of subunit IV in Q-binding and structural integrity of the R. sphaeroides cytochrome b-c(1) complex has been further established by molecular genetics studies(12, 13) . The gene for subunit IV (fbcQ) has been cloned and sequenced(12) . The fbcQ cistron is 372 base pairs long, encodes 124 amino acid residues, and is contained in a 4.7-kilobase pair BamHI R. sphaeroides DNA fragment. When fbcQ is deleted from the R. sphaeroides chromosome, the resulting strain (RSDeltaIV) requires a period of adaptation before the start of photosynthetic growth(13) . The cytochrome b-c(1) complex in adapted chromatophores is labile to detergent treatment (75% inactivation) and shows a 4-fold increase in the K for Q(2)H(2)(13) . The first two changes (adaptation time and detergent lability) indicate a structural role of subunit IV; the third change (K increase) indicates its Q-binding function. Introducing wild-type fbcQ on a stable low copy number plasmid, pRK415, into RSDeltaIV restores photosynthetic growth behavior, the apparent K for Q(2)H(2), and tolerance to detergent treatment to the level of wild-type cells.

The Q-binding domain in subunit IV is located at residues 77-124, as determined by isolation and sequencing of an [^3H]azido-Q-labeled, V8-digested peptide(12) . The most likely Q-binding region is at residues 77-86, which lies on the cytoplasmic side of the chromatophore membrane. By using site-directed mutagenesis techniques coupled with in vivo complementation, tryptophan-79 has been identified to be responsible for Q-binding, and amino acid residues 6-11 are responsible for the structural role of subunit IV(14) .

Although mutagenesis coupled with in vivo complementation has generated useful information in structure-function studies of subunit IV, this approach is often complicated by mutational effects on the complex assembly and stability of the mutated protein. An approach using expressed mutated recombinant protein to reconstitute, in vitro, a subunit IV-lacking complex (three-subunit core complex) alleviates the problem of assembly and stability of mutated protein and thus complements the in vivo complementation approach. In order to employ this in vitro reconstitution approach, a reconstitutively active, three-subunit core cytochrome b-c(1) complex and an over-expressed, functionally active subunit IV are needed.

The three-subunit core complex is available in our laboratory. This complex is prepared from adapted chromatophores of RSDeltaIV by a method involving dodecylmaltoside solubilization and DEAE-Biogel A and DEAE-Sepharose 6 B column chromatography(13) . Recently, we have over-expressed subunit IV in Escherichia coli as a glutathione S-transferase (GST) fusion protein by using the pGEX expression vector system(15) . The pGEX expression system allows one-step affinity purification of the recombinant fusion protein with glutathione-agarose gel(16) . The recombinant protein is then released from the fusion protein by thrombin cleavage(17) . Herein we report construction of a subunit IV expression vector, pGEX/RSIV, conditions for high expression of an active soluble form of the GST-RSIV fusion protein in E. coli JM109, and isolation and characterization of pure recombinant subunit IV. Reconstitution of the R. sphaeroides cytochrome b-c(1) complex from the three-subunit core complex and recombinant subunit IV is described, and properties of the reconstituted complex are examined. The amino acid residues essential for reconstitutive activity of subunit IV are also identified.


EXPERIMENTAL PROCEDURES

Materials

All restriction endonucleases were obtained from either Promega or Life Technologies, Inc. Altered Sites in vitro Mutagenesis System was purchased from Promega. Expression vector pGEX-2T, fast protein liquid chromatography columns of Superose 6 and Superose 12 were from Pharmacia Biotech Inc. Primers and oligonucleotides were synthesized by the DNA/Protein Core Facility of Oklahoma State University. T4 DNA polymerase and T4 DNA ligase were from Promega. Shrimp alkaline phosphatase was from Amersham Corp. Goat anti-rabbit IgG alkaline phosphatase conjugate and protein A-horseradish peroxidase conjugate were from Bio-Rad. Pure nitrocellulose membrane for Western blots was from Schleicher & Schuell. Glutathione (reduced form), glutathione-agarose gel, phenylmethylsulfonyl fluoride, leupeptine, isopropyl-beta-D-thiogalactoside (IPTG), horse cytochrome c, type III, and thrombin were from Sigma. 2,3-Dimethoxy-5-methyl-6-geranyl-1,4-benzoquinol (Q(2)H(2)) was synthesized in our laboratory as described previously(18) . Antibodies against subunit IV were raised in rabbits and purified by the previously described method(7) .

Growth of Bacteria

R. sphaeroides cells, wild-type (NCIB8253), RSDeltaIV, and complement strains, were grown at 30 °C in Sistrom's minimal medium A, as described previously(13) . E. coli JM109 or KS1000 were grown aerobically at 37 °C in LB broth. Plasmids were maintained in E. coli in the presence of ampicillin (100 µg/ml).

Enzyme Preparation and Assay

Chromatophores were prepared from photosynthetically grown wild-type, RSDeltaIV, and complement cells by the method reported previously(13) . The cytochrome b-c(1) complexes were prepared from chromatophores by the method of Ljungdahl et al. (3) with modifications (13) . Cytochrome b-c(1) complex activity was assayed as previously reported(13) . An appropriate amount of enzyme preparation was added to an assay mixture (1 ml) containing 50 mM Na/K phosphate buffer, pH 7.0, 1 mM EDTA, 50 µM cytochrome c, and 25 µM Q(2)H(2). For determination of apparent K(m) for Q(2)H(2), various concentrations of Q(2)H(2) were used. Cytochrome b-c(1) complex activity was determined by measuring the reduction of cytochrome c (the increase in absorbance at 550 nm) in a Cary spectrophotometer, model 219, or Shimadzu UV-2101PC, at 23 °C. Nonenzymatic oxidation of Q(2)H(2) was determined under the same conditions in the absence of enzyme. A millimolar extinction coefficient of 18.5 was used to calculate the concentration of cytochrome c.

Recombinant DNA Techniques

Restriction enzyme digestion, large scale isolation and mini-preparation of plasmid DNA, agarose electrophoresis, purification of DNA fragments from gel matrices, and immunological screening of transformants for production of subunit IV with antibodies against subunit IV were performed according to the protocols described by Sambrook et al.(19) . Goat anti-rabbit IgG alkaline phosphatase conjugate was used as the second antibody in the screening of transformants. Site-directed mutagenesis was performed using site-directed in vitro mutagenesis with the Altered Sites System from Promega(20) .

Isolation of Recombinant Subunit IV

400 ml of an overnight culture of E. coli JM109/pGEX/RSIV was used to inoculate 11.5 liters of LB broth containing 50 µg/ml ampicillin. The resulting culture was incubated at 37 °C with vigorous shaking until the OD reached 0.8 (approximately 2 h). To induce synthesis of the GST/RSIV fusion protein, IPTG was added to the culture to a final concentration of 0.5 mM. Cells were grown at 37 °C for 3 h and then harvested by centrifugation at 8,000 times g for 20 min. About 52 g of cells were pelleted and resuspended in 150 ml of 20 mM Na/K phosphate, pH 7.3, containing 150 mM NaCl (PBS). Cells were broken by sonication at 30 milliwatts for a total of 80 s: four 20-s pulses separated by 3-min intervals at 0 °C. During sonication, phenylmethylsulfonyl fluoride (100 mM in absolute alcohol) and leupeptin (10 mg/ml) were added to the cell suspension to final concentrations of 1 mM phenylmethylsulfonyl fluoride and 0.01 mg/ml leupeptin. Triton X-100 was added to the broken cell suspension to a final concentration of 1%. The suspension was then incubated for 30 min at 0 °C and centrifuged at 30,000 times g for 20 min. The supernatant was collected and mixed with 50 ml of glutathione-agarose gel equilibrated with PBS. The gel mixture was gently shaken for 30 min at 0 °C and centrifuged at 1000 times g for 5 min to collect the beads. After washing five times with 200 ml of PBS, the beads were suspended in 50 mM Tris-Cl, pH 7.5, and packed into a column (1.6 times 20 cm). The GST/subunit IV fusion protein was eluted from the column with 10 mM glutathione in 50 mM Tris-HCl, pH 8.0, and dialyzed overnight against the same buffer. The dialyzed sample was concentrated to 10 mg/ml by Centricon-30 and treated with thrombin (1/500, w/w) at room temperature for 1 h to release subunit IV from GST. The released GST was removed by glutathione beads. The thrombin present in the GST-free sample was removed by gel filtration with a Superose-12 fast protein liquid chromatography column.

SDS-PAGE(21) , nondenaturing blue gel electrophoresis(22) , Western blots(23) , and protein (24) and cytochromes b and c(1) contents (13) were determined according to methods previously described.

Titration of recombinant subunit IV by N-bromosuccimide was performed according to the method described by Spande and Witkop(25) . The amount of tryptophan being oxidized by N-bromosuccimide was determined by measuring the decrease in absorbance at 280 nm. A molar extinction coefficient of 585 M cm for tryptophan in 50 mM Tris-Cl, pH 8.0, containing 300 mM NaCl and 0.01% dodecylmaltoside was used for calculations.


RESULTS AND DISCUSSION

Construction of the Expression Vector for Subunit IV (pGEX/RSIV)

It has been reported (16) that in E. coli, recombinant polypeptides produced as fusion proteins as glutathione S-transferase (GST) using the pGEX vector system can be purified to homogeneity by a one-step affinity column chromatography with glutathione-agarose gel followed by thrombin cleavage. The very high yields reported in studies with pGEX combined with the simple purification format prompted us to use the pGEX system to express R. sphaeroides subunit IV in E. coli. Fig. 1summarizes the protocol used for construction of the subunit IV expression vector, pGEX/RSIV. Because the BamHI site located right next to the thrombin cleavage site is a unique site in the pGEX-2T vector and is missing in the subunit IV structural gene (fbcQ), an in-frame fusion of the subunit IV gene with the GST gene on the pGEX-2T plasmid was achieved by generating a BamHI fragment encoding subunit IV and subsequently ligating it into the BamHI site of the pGEX-2T plasmid. To obtain the BamHI fragment encoding subunit IV, a BamHI recognition sequence (GGATCC) immediately upstream from the start codon (ATG) of subunit IV was created by site-directed mutagenesis. A 1.6-base pair BamHI fragment cloned into the pSelect plasmid generated pSelect/RSIV was used as the template for mutagenesis. A mutant oligonucleotide, CTGGAGACGCCGGATCCATGTTCTCATT, and an ampicillin repair oligonucleotide were incubated in the mutagenesis system. This mutagenesis procedure produced greater than 70% mutants. The resulting plasmid, pSelect/RSIV, was digested with BamHI to produce a 505-base pair fragment containing fbcQ. This BamHI fragment was ligated into pGEX-2T to generate pGEX/RSIV. pGEX/RSIV was transformed into E. coli JM109. Transformants producing the GST-RSIV fusion protein were identified by immunological screening of colonies with antibodies against subunit IV.


Figure 1: Construction of the expression vector for R. sphaeroides subunit IV, pGEX/RSIV.



Expression and Purification of Recombinant Subunit IV

The production of active soluble GST-RSIV recombinant fusion protein in E. coli transformed with pGEX/RSIV plasmid was found to be IPTG induction- and growth-time dependent. Fig. 2shows the yields of glutathione-agarose gel-purified GST-RSIV fusion protein from cells harvested at various induction growth times. The yield of fusion protein was estimated by the color intensity of the 41-kDa protein band (GST-RSIV fusion protein), which reacted with antibodies against subunit IV and antibodies against GST. The yield increased as the induction growth time was increased to a maximum yield that was obtained when cells were harvested 3 h after growth induction. When cells were grown for 5 h, there was a 20% decrease in yield, suggesting that the recombinant protein is unstable and susceptible to protease digestion.


Figure 2: Recovery of purified GST-RSIV fusion protein from cells after various IPTG induction growth times. A, lane 1 is molecular weight references. Lane 2 represents cells grown without IPTG. Lanes 3-6 represent cells grown for 1, 2, 3, and 5 h, respectively, after the addition of IPTG in LB media containing 50 µg/ml ampicillin. The isolation of GST-RSIV fusion protein by affinity glutathione-agarose gel is as described under ``Experimental Procedures.'' 30 µl of glutathione-agarose eluates were applied to SDS-PAGE. B, the proteins on the gel of A were electrophoretically transferred to a nitrocellulose membrane without staining and then reacted with anti-subunit IV antibodies. Protein A-horseradish peroxidase conjugate was used as a second antibody.



The susceptibility of recombinant subunit IV to the protease digestion is further evident from the presence of three smaller molecular mass protein bands, with apparent molecular sizes of 31, 28, and 26 kDa, following SDS-PAGE of glutathione-agarose eluates (see Fig. 2A). The 31- and 28-kDa protein bands, which reacted with antibodies against subunit IV and antibodies against GST and disappeared after thrombin digestion, may derive from partial C-terminal digestion of recombinant fusion protein. The 26-kDa protein band, which reacted only with antibodies against GST, may result from the complete digestion of subunit IV from the fusion protein.

The addition of protease inhibitors, such as phenylmethylsulfonyl fluoride and leupeptin, during cell extract preparation did not prevent degradation of the recombinant subunit IV. Expression of the GST-RSIV fusion protein in E. coli KS1000, which is deficient in the Tsp protease, a periplasmic protease, also did not prevent the degradation of recombinant subunit IV. The Tsp protease (26) was reported to degrade cytoplasmically expressed proteins in crude cell extracts, and presumably it can degrade proteins expressed in the periplasm as well.

It should be noted that our routine cell extract procedure included treatment with 1% Triton X-100. If this treatment was omitted, the yield of soluble recombinant GST-RSIV fusion protein decreased 55%. This suggests that some GST-RSIV fusion protein is either in a membrane fraction or an inclusion body aggregate that can be solubilized by Triton X-100 while maintaining the GST-active site recognizable by glutathione-agarose gel. Recombinant GST-RSIV fusion protein obtained from cell extracts prepared with Triton X-100 has the same molecular size and reconstitutive activity as protein obtained without Triton X-100 treatment.

Recombinant subunit IV was released from the fusion protein by thrombin digestion. When the fusion protein was incubated with thrombin at a weight ratio of 1:500 at room temperature, about 80% of the subunit IV was recovered within 1 h. Although prolonged incubation can complete cleavage, it is often accompanied by irreversible denaturation of protein. Therefore, a 1-h digestion time was used. The released GST and uncleaved GST-RSIV fusion protein in the treated sample were removed by glutathione-agarose beads, and thrombin was removed by gel filtration.

Properties of Recombinant Subunit IV

Isolated recombinant subunit IV is soluble in aqueous solution but exists in a highly aggregated form. The apparent molecular mass of the isolated recombinant protein is over 1000 kDa, as determined by fast protein liquid chromatography gel filtration with Sepharose-12 in 50 mM Tris-Cl buffer, pH 8.0. Aggregation is apparently due to the hydrophobic transmembrane segment of the peptide chain. The hydropathy plot of subunit IV suggests the presence of a definitive transmembrane helix (12) near the C-terminal end of the protein. Aggregated subunit IV was deaggregated to decamer (145,000), pentamer (75,000), and trimer (45,000) states in the presence of 0.01, 0.1, and 0.2% dodecylmaltoside, respectively, in 50 mM Tris-Cl buffer, pH 8.0, containing 300 mM NaCl. The soluble hydrophobic aggregation of isolated subunit IV resembles isolated recombinant mitochondrial QPc-9.5 kDa (27) in which the protein exhibits as a soluble aggregate in aqueous solution and deaggregates to monomer form in the presence of detergent.

Following SDS-PAGE, isolated subunit IV showed a single protein band that corresponds to subunit IV (M(r) = 14,384) of R. sphaeroides cytochrome b-c(1) complex (see Fig. 3). The partial N-terminal amino acid sequence of recombinant subunit IV was determined to be GSMFSFI-, indicating that two additional amino acid residues, glycine and serine, are present at the N terminus of subunit IV. These two residues result from the recombinant manipulation. The true molecular mass of recombinant subunit IV should be 201 daltons more than that of native subunit IV.


Figure 3: SDS-PAGE of recombinant subunit IV. Lane 1, purified recombinant subunit IV (3 µg). Lane 2, purified wild-type cytochrome b-c(1) complex (20 µg). Lane 3, the molecular weight reference markers.



Functional Activity of Recombinant Subunit IV

Previous studies established that subunit IV is an essential subunit of R. sphaeroides cytochrome b-c(1) complex. It is required for catalytic activity as well as structural integrity of the complex. Cytochrome b-c(1) complex activity in subunit IV-deficient chromatophores of adapted RSDeltaIV cells is more labile to detergent treatment than that from wild-type cells, indicating that subunit IV is essential for the structural integrity of the complex. The three-subunit core complex, prepared from adapted chromatophores of RSDeltaIV cells, has only 25% of the activity of the four-subunit enzyme, indicating that subunit IV is essential for catalytic activity of the complex. Thus, the functional activity of recombinant subunit IV can be assessed by its ability to increase the tolerance of the cytochrome b-c(1) complex in RSDeltaIV chromatophores to detergent treatment and its ability to restore cytochrome b-c(1) complex activity to the three-subunit core complex.

Table 1shows the protective effect of subunit IV on the RSDeltaIV cytochrome b-c(1) complex toward detergent treatment. When RSDeltaIV chromatophores were added to varying amounts of recombinant subunit IV before being subjected to dodecylmaltoside treatment, the cytochrome b-c(1) complex activity in the detergent-solubilized chromatophore fraction increased with the amount of recombinant subunit IV added. Maximum restoration (68%) was reached when recombinant subunit IV and the RSDeltaIV b-c(1) complex were present in a 1:1 molar ratio. The addition of subunit IV to the wild-type or complement chromatophores had no effect on cytochrome b-c(1) complex activity upon detergent solubilization. The further addition of subunit IV to the subunit IV-treated, detergent-solubilized chromatophores fraction did not further increase cytochrome b-c(1) complex activity. The incomplete restoration of detergent tolerance to the cytochrome b-c(1) complex in RSDeltaIV chromatophores by recombinant subunit IV may result from a decrease in binding affinity of the three-subunit core complex to recombinant subunit IV in the presence of high concentrations of dodecylmaltoside, as used in solubilization.



Fig. 4shows the restoration of the cytochrome b-c(1) complex activity from the purified three-subunit core complex by recombinant subunit IV. When the core complex was incubated with varying concentrations of subunit IV, activity increased as the concentration of subunit IV increased. Maximum restoration was reached when 1 mol of subunit IV/mol of three-subunit core complex was used. The activity was restored to the same level as that of the wild-type complex, indicating that recombinant subunit IV is fully active. Because recombinant subunit IV can fully restore cytochrome b-c(1) complex activity to the three-subunit core complex, the structural requirement for the amino acid residues near the N terminus of subunit IV are not stringent, as recombinant subunit IV has two amino acid residues, serine and glycine, added to the N terminus. This is in line with the gene deletion study showing that the first five amino acid residues from the N terminus are not essential for subunit IV(14) . Restoration of the cytochrome b-c(1) complex activity to the three-subunit complex by subunit IV was found to be incubation time-dependent (see Fig. 5). Maximum activity restoration was observed after 1 h of incubation at 0 °C. The incubation time dependence of reconstitution may result from deaggregation of recombinant subunit IV or conformational change of the reconstituted complex.


Figure 4: Effect of subunit IV concentration on restoration of ubiquinol-cytochrome c reductase activity from the three-subunit core complex. Aliquots (40 µl) of the wild-type (times) and the three-subunit core cytochrome b-c(1) complexes (circle), 0.45 mg/ml in 50 mM Tris-HCl, pH 8.0, containing 300 mM NaCl and 0.01% dodecyl maltoside were added to the indicated amounts of purified subunit IV in 50 mM Tris-Cl, pH 8.0. After 1 h of incubation at 0 °C, aliquots were withdrawn for ubiquinol-cytochrome c reductase activity assay. Each data point represents the average of duplicate assays.




Figure 5: Effect of incubation time on activity restoration of three-subunit core cytochrome b-c(1) complex by subunit IV. 26 µg of three-subunit cytochrome b-c(1) complex in 50 µl of 50 mM Tris-Cl, pH 8.0, containing 0.01% dodecylmaltoside and 300 mM NaCl was added to 4 µg of isolated recombinant subunit IV in 50 µl of 50 mM Tris-Cl buffer, pH 8.0, and incubated at 0 °C. At indicated time intervals, 5-µl aliquots were withdrawn and assayed for ubiquinol-cytochrome c reductase activity.



The addition of recombinant subunit IV to the three-subunit core complex not only restored the enzymatic activity but also the Q-binding environment. Fig. 6shows the Q(2)H(2)-dependent activity titration curves for the wild-type, reconstituted, and RSDeltaIV cytochrome b-c(1) complexes. The apparent K(m) for Q(2)H(2) of wild-type, reconstituted, and three-subunit core cytochrome b-c(1) complexes were 2.2, 2.5, and 10.8, respectively. The restoration of the K(m) in the reconstituted complex further confirms the involvement of subunit IV in Q binding of this complex.


Figure 6: Titration of ubiquinol-cytochrome c reductase activity in wild-type, three-subunit core, and reconstituted cytochrome b-c(1) complexes with various concentrations of Q(2)H(2). Aliquots of wild-type (circle), RSDeltaIV (times), and reconstituted (up triangle) cytochrome b-c(1) complexes in 50 mM Tris-HCl, pH 8.0, containing 0.01% dodecylmaltoside and 300 mM NaCl were added to a 1-ml assay mixture containing the indicated concentrations of Q(2)H(2). Reconstituted cytochrome b-c(1) complex was prepared by adding 10 µl of purified subunit IV (1.0 mg/ml) to 140 µl (0.45 mg/ml) of RSDeltaIV complex and incubated at 0 °C for 1 h.



The ubiquinol-cytochrome c reductase activity in the reconstituted four-subunit complex is fully sensitive to antimycin treatment. A 50% inhibition was found with 1 mol of antimycin/mol cytochrome c(1), a level identical to that observed for the wild-type cytochrome b-c(1) complex.

The reconstituted cytochrome b-c(1) complex has the same molecular size as the wild-type complex as revealed by the same electrophoretic mobility of these two complexes in a nondenaturing blue gel electrophoresis (data not shown). The apparent molecular mass of these two complexes was estimated to be around 240 kDa, indicating that they exist in dimer form. The isolated three-subunit core complex also occurs in dimer form with a slightly higher electrophoretic mobility than the wild-type complex in nondenaturing blue gel. Because the isolated recombinant subunit IV in aqueous solution has an apparent molecular mass of over one million, whereas the reconstituted cytochrome b-c(1) complex has only 240 kDa, deaggregation of subunit IV must occur during the reconstitution process. This correlates with the observation that incubation time is required for maximum reconstitution.

Involvement of Tryptophan Residues in Subunit IV for Its Reconstitutive Activity

Table 2shows the effects of some commonly used protein modifying reagents on the reconstitutive activity of recombinant subunit IV. Among the modifiers tested, only N-chlorosuccimide or N-bromosuccimide, a tryptophan modifying reagent, inhibited the reconstitutive activity of subunit IV, indicating that tryptophan(s) is essential for subunit IV in its interaction with the three-subunit core complex or for the catalytic activity of the complex. The latter possibility was ruled out, as the intact four-subunit complex is not sensitive to N-bromosuccimide treatment (up to 10 mol/mol protein).



Because there are five tryptophans in subunit IV, the number of tryptophans involved was unclear. To address this question, the correlation between loss of reconstitutive activity of recombinant subunit IV and tryptophan residues in subunit IV reacting with N-bromosuccimide was established. When recombinant subunit IV was incubated with various concentrations of N-bromosuccimide at room temperature for 10 min, the reaction of N-bromosuccimide with tryptophan residues was directly proportional to the loss of reconstitutive activity of subunit IV, up to a 6 molar excess of N-bromosuccimide (Fig. 7). About 70% of the reconstitutive activity of subunit IV was abolished when one tryptophan residue was modified. The direct correlation between activity loss and the tryptophan modification suggests that the first tryptophan residue modified in subunit IV is required for interaction with the three-subunit core complex. This tryptophan residue is more reactive toward N-bromosuccimide than other tryptophan residues in subunit IV. N-Bromosuccimide reacted with maximum of three tryptophans in subunit IV even though there are five tryptophans present. Because isolated recombinant subunit IV is in decamer form under the modification conditions, the N-bromosuccimide inactive tryptophans must be buried inside the aggregate. When wild-type four-subunit and three-subunit core complexes were incubated with a 10 molar excess of N-bromosuccimide at room temperature for 10 min, no loss of activity was observed. This indicates that the tryptophan residue in subunit IV responsible for interaction with other core subunits is shielded by their interacting subunit in the cytochrome b-c(1) complex. Identification of the subunit IV tryptophan residue responsible for this interaction is currently in progress in our laboratory.


Figure 7: Correlation between tryptophan modification and inactivation of recombinant subunit IV. 1-ml aliquots of recombinant subunit IV, 1 mg/ml, in 50 mM Tris-Cl, pH 8.0, containing 300 mM NaCl and 0.01% dodecylmaltoside were added to 25 µl of water containing indicated amounts of N-bromosuccimide (NBS) at room temperature. After incubation at room temperature for 10 min, the amount of tryptophan oxidized by N-bromosuccimide in each sample (times) was determined as described under ``Experimental Procedures.'' Immediately after the oxidized tryptophan was quantitized, 3-µl aliquots were withdrawn from each tube, added to 2-µl aliquots of tryptophan (50 mM), incubated for another 5 min, and reconstituted with 20 µl of the three-subunit core complex, 1 mg/ml, in 50 mM Tris-HCl, pH 8.0, containing 300 mM NaCl and 0.01% dodecylmaltoside. Ubiquinol-cytochrome c reductase activity (circle) was assayed after incubation at 0 °C for 1 h.




FOOTNOTES

*
This work was supported in part by Grant MCB-9305455 from the National Science Foundation. This publication is approved by the director of Agricultural Experiment Station, Oklahoma State University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

(^1)
The abbreviations used are: Q, ubiquinone; GST, glutathione S-transferase; IPTG, isopropyl beta-D-thiogalactopyranoside; Q(2)H(2), 2,3-dimethoxy-5-methyl-6-geranyl-1,4-benzoquinone; PAGE, polyacrylamide gel electrophoresis.


REFERENCES

  1. Trumpower, B. L., and Gennis, R. B. (1994) Annu. Rev. Biochem. 63, 675-716 [CrossRef][Medline] [Order article via Infotrieve]
  2. Yu, L., Mei, Q.-C., and Yu, C. A. (1984) J. Biol. Chem. 259, 5752-5760 [Abstract/Free Full Text]
  3. Ljungdahl, P. O., Pennoyer, J. D., Robertson, D. E., and Trumpower, B. (1987) Biochim. Biophys. Acta 891, 227-241 [Medline] [Order article via Infotrieve]
  4. Purvis, D. J., Theiler, R., and Niederman, R. A. (1990) J. Biol. Chem. 265, 1208-1215 [Abstract/Free Full Text]
  5. Andrew, K., Crofts, A. R., and Gennis, B (1990) Biochemistry 29, 2645-2651 [Medline] [Order article via Infotrieve]
  6. Gennis, R. B., Barquera, B., Hacker, B., Van Doren, R. S., Armaud, S., Crofts, A. R., Davidson, E., Gray, K. A., and Daldal, F. (1993) J. Bioenerg. Biomembr. 25, 195-209 [Medline] [Order article via Infotrieve]
  7. Yu, L., and Yu, C. A. (1991) Biochemistry 30, 4934-4939 [Medline] [Order article via Infotrieve]
  8. Yu, L., and Yu, C. A. (1987) Biochemistry 26, 3658-3664
  9. Kirauciunas, A., Yu, L., Yu, C. A., Max Wynn, R., and Knaff, D. (1989) Biochim. Biophys. Acta 976, 70-76 [Medline] [Order article via Infotrieve]
  10. Robertson, D. E., Ding, H., Chelminski, P. R., Slaughter, C., Hsu, J., Moomaw, C., Tokito, M., Dadal, F., and Dutton, P. L. (1993) Biochemistry 32, 1310-1317 [Medline] [Order article via Infotrieve]
  11. Yang, X., and Trumpower, B. L. (1988) J. Biol. Chem. 261, 12282-12289 [Abstract/Free Full Text]
  12. Usui, S., and Yu, L. (1991) J. Biol. Chem. 266, 15644-15649 [Abstract/Free Full Text]
  13. Chen, Y.-R., Usui, S., Yu, C. A., and Yu, L. (1994) Biochemistry 33, 10207-10214 [Medline] [Order article via Infotrieve]
  14. Chen, Y.-R., Shenoy, S. K., Yu, C. A., and Yu, L. (1995) J. Biol. Chem. 270, 11496-11501 [Abstract/Free Full Text]
  15. Smith, D. B., and Johnson, K. S. (1988) Gene (Amst.) 67, 31-40
  16. Johnson, K. S., Harrison, G. B. L., Lightowlers, M. W., O'Hoy, K. L., Cougle, W. G., Dempster, R. P., Lawrence, S. B., Vinton, J. G., Heath, D. D., and Rickard, M. D. (1989) Nature 338, 585-587 [CrossRef][Medline] [Order article via Infotrieve]
  17. Abath, F. G. C., and Simpson, A. J. G. (1990) Peptide Res. 3, 167-168
  18. Yu, C. A., and Yu, L. (1982) Biochemistry 21, 4096-4101 [Medline] [Order article via Infotrieve]
  19. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  20. Altered Sites (TM) in vitro Mutagenesis System, Technical Manual, Promega Corporation
  21. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  22. Schägger, H., and Von Jagow, G. (1991) Anal. Biochem. 199, 223-231 [Medline] [Order article via Infotrieve]
  23. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Abstract]
  24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 [Free Full Text]
  25. Spande, T. F., and Witkop, B (1967) Methods Enzymol. 11, 498-532
  26. Siber, K. R., Keiler, K. C., and Sauer, R. T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 295-299 [Abstract]
  27. Yu, L., Deng, K.-P., and Yu, C. A. (1995) J. Biol. Chem. 270, 25634-25638 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.